Shook & Stone Opens Up “An Ideal Lawyer’s Portrait: Representation Matters” 2026 Scholarship 
Marketing 1on1 Announces the Addition of Local Citations to Its Backlink Service Offerings 
Think Business, Think Hong Kong strengthens Italy-Hong Kong ties and opens new path for Asian collaboration 
FUTR Announces Q1 2026 Financial Results Larimar Therapeutics Announces $95 Million Private Placement Financing
BALA CYNWYD, Pa., May 21, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab) Subcutaneous (SC) Formulation for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
Company Announcement Janssen received a positive CHMP opinion for DARZALEX® SC (daratumumab and hyaluronidase-fihj) in…
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency
European Commission decision anticipated in July BOSTON, May 21, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals,…
Albireo Receives Positive CHMP Opinion for Bylvay™ (odevixibat) for Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
– Bylvay has the potential to become first approved drug to treat all forms of…
Zymergen to Present at UBS Global Healthcare Virtual Conference
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Biofacturing leader Zymergen today announced the company will…
Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Treatment of Women With Uterine Fibroids
CHMP opinion recommending approval based on data from the Phase 3 LIBERTY program in women…
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Brings Best-in-Class Team to Psychedelics Development
NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB:…
ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line development
PMN310 potential best in class antibody candidate for treatment of Alzheimer’s disease TORONTO and CAMBRIDGE,…
Cullinan Oncology Announces Management Transition
CAMBRIDGE, Mass., May 21, 2021 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), an…
XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) recently learned its…
Soleno Therapeutics to Host Webinar Highlighting DCCR for Treatment of Prader-Willi Syndrome at European Congress on Endocrinology 2021
European Key Opinion Leaders to Participate in Event REDWOOD CITY, Calif., May 21, 2021 (GLOBE…
Gracell Biotechnologies to Host Clinical Update Conference Call and Webcast on June 4, 2021 at 11:00am EDT
SUZHOU, China and PALO ALTO, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc….
Humacyte Presents Advances in Whole-Lung Engineering
Laboratory and pre-clinical models of whole-lung engineering inform roadmap for building a functional lung alveolus,…
Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day – May 22nd
Provides educational resources for both patients and healthcare providers SAN DIEGO, May 21, 2021 (GLOBE…
Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform
Collaboration aims to develop a next-generation AAV production platform to help accelerate Biogen’s efforts to…
Tony Gibney Joins InflaRx Board of Directors
JENA, Germany, May 21, 2021 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
Nabriva Therapeutics to Present at the Jefferies Virtual Healthcare Conference
DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 21, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics…
TELA Bio to Participate in Upcoming Investor Conferences
MALVERN, Pa., May 21, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Amicus Therapeutics Announces Upcoming Presentations at the 16th International Congress on Neuromuscular Diseases
PHILADELPHIA, May 21, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), today announced two posters…
Autolus Notice of Annual General Meeting (AGM) on Friday, June 18, 2021
Attendance in person is not permitted LONDON, May 21, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics…